July 26, 2016
Recommended Topic Related To:

Tazorac Cream

"The U.S. Food and Drug Administration today approved Cosentyx (secukinumab) to treat adults with moderate-to-severe plaque psoriasis.  

Psoriasis is a skin condition that causes patches of skin redness and irritation. Psoriasis is"...


Tazorac Cream

How Supplied


Plaque Psoriasis

TAZORAC® (tazarotene) Cream, 0.05% and 0.1% are indicated for the topical treatment of patients with plaque psoriasis.

Acne Vulgaris

TAZORAC® (tazarotene) Cream, 0.1% is also indicated for the topical treatment of patients with acne vulgaris.



It is recommended that treatment starts with TAZORAC® Cream, 0.05%, with strength increased to 0.1% if tolerated and medically indicated. Apply a thin film (2 mg/cm²) of TAZORAC® Cream once per day, in the evening, to cover only the psoriatic lesions. If a bath or shower is taken prior to application, the skin should be dry before applying the cream. If emollients are used, they should be applied at least an hour before application of TAZORAC® Cream. Because unaffected skin may be more susceptible to irritation, application of TAZORAC® Cream to these areas should be carefully avoided.


Cleanse the face gently. After the skin is dry, apply a thin layer (2 mg/cm²) of TAZORAC® Cream 0.1% once per day, in the evening, to the skin areas where acne lesions appear. Use enough to cover the entire affected area.

TAZORAC® Cream is for topical use only. TAZORAC® Cream is not for ophthalmic, oral, or intravaginal use. If contact with eyes occurs, rinse thoroughly with water.


Dosage Forms And Strengths

Cream, 0.05% and 0.1%. Each gram of TAZORAC® Cream, 0.05% and 0.1% contains 0.5 mg and 1 mg of tazarotene, respectively in a white cream base.

Storage And Handling

TAZORAC® Cream is a white cream available in concentrations of 0.05% and 0.1%. It is supplied in a collapsible aluminum tube with a tamper-evident aluminum membrane over the opening and a white polypropylene screw cap, in 30 g and 60 g sizes.

TAZORAC® Cream, 0.05% TAZORAC® Cream, 0.1%
30 g NDC 0023-9155-30 NDC 0023-9156-30
60 g NDC 0023-9155-60 NDC 0023-9156-60


Store at 20°C to 25°C (68°F to 77°F). Excursions permitted from -5°C to 30°C (23°F to 86°F).

Manufactured by: Allergan, Inc., Irvine, CA 92612, U.S.A. Revised: December/2013

This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 1/22/2014

How Supplied

Tazorac Cream - User Reviews

Tazorac Cream User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Tazorac Cream sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Women's Health

Find out what women really need.